Real-time and Bedside Charting Data for the Study and Control Unit for All Study Phases
| Study unit real-time charting rate phase | N | % Real time | 95% CI | χ2 (df1) | p | N | Odds ratio | 95% CI |
| Preintervention | 16,372 | 59.5 | 0.587–0.602 | |||||
| Intervention | 20,751 | 72.5 | 0.719–0.732 | 706.04 | <0.001 | 37,123 | 1.80 | 1.72–1.88 |
| Postintervention | 15,421 | 75.8 | 0.751–0.765 | 964.95 | <0.001 | 31,793 | 2.14 | 2.04–2.24 |
| Follow-up | 2,536 | 75.2 | 0.735–0.769 | 230.26 | <0.001 | 18,908 | 2.07 | 1.88–2.27 |
| Control unit real-time charting rate phase | N | % Real time | 95% CI | χ2 | p | N | Odds ratio | 95% CI |
| Preintervention | 18,453 | 53.5 | 0.528–0.542 | |||||
| Intervention | 24,245 | 59.2 | 0.586–0.598 | 139.20 | <0.001 | 42,698 | 1.26 | 1.21–1.31 |
| Postintervention | 18,231 | 56.9 | 0.562–0.576 | 43.00 | <0.001 | 36,684 | 1.15 | 1.10–1.20 |
| Follow-up | 2,603 | 57.2 | 0.552–0.591 | 12.38 | <0.001 | 21,056 | 1.16 | 1.07–1.26 |
| Study unit bedside charting rate phase | N | % Bedside | 95% CI | χ2 | p | N | Odds ratio | 95% CI |
| Preintervention | 16,372 | 40.6 | 0.399–0.414 | |||||
| Intervention | 20,751 | 63.0 | 0.623–0.636 | 1,837.60 | <0.001 | 37,123 | 2.48 | 2.38–2.59 |
| Postintervention | 15,421 | 66.6 | 0.659–0.673 | 2,152.58 | <0.001 | 31,793 | 2.91 | 2.78–3.05 |
| Follow-up | 2,536 | 58.5 | 0.565–0.604 | 285.80 | <0.001 | 18,908 | 2.05 | 1.89–2.24 |
| Control unit bedside charting rate phase | N | % Bedside | 95% CI | χ2 | p | N | Odds ratio | 95% CI |
| Preintervention | 18,453 | 33.6 | 0.329–0.343 | |||||
| Intervention | 24,245 | 41.0 | 0.404–0.417 | 246.21 | <0.001 | 42,698 | 1.38 | 1.32–1.43 |
| Postintervention | 18,231 | 38.5 | 0.378–0.393 | 96.81 | <0.001 | 36,684 | 1.24 | 1.19–1.29 |
| Follow-up | 2,603 | 43.8 | 0.419–0.458 | 104.05 | < 0.001 | 21,056 | 1.54 | 1.42–1.68 |
-
Chi-square, p, N, odds ratio, and confidence interval calculated from comparisons to the preintervention data for each phase.









